Inspire Medical Systems, Inc. (INSP) Institutional Ownership & Insider Trading

275 institutions reported holding Inspire Medical Systems, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 7 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

INSPInspire Medical Systems, Inc.Follow INSP — free

Medical Devices · Healthcare

—

Price chart with a free account

Market cap: 2.1B
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 2 Nov, in 9 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

275 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +8.8%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	275	38	+8.8%	92	56	73	81
Mar 26	299	35	-3.2%	113	44	94	83
Dec 25	337	34	+10.5%	107	69	104	64
Sep 25	315	31	-7.2%	94	50	120	86
Jun 25	353	34	-1.9%	110	41	123	47
Mar 25	356	34	+1.9%	125	50	105	44
Dec 24	353	33	-1.4%	106	45	114	40
Sep 24	340	33	-2.7%	102	70	103	50

Inspire Medical Systems, Inc. — questions

Who owns Inspire Medical Systems, Inc. stock?: 275 institutions reported Inspire Medical Systems, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (16.4%), WELLINGTON MANAGEMENT GROUP LLP (8.2%), VANGUARD PORTFOLIO MANAGEMENT LLC (7.2%).
Are Inspire Medical Systems, Inc. insiders buying or selling?: 7 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Inspire Medical Systems, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.